Medical Xpress - Cardiology

JANUARY 18, 2024

Receipt of a cardiac-resynchronization therapy-defibrillator (CRT-D) offers long term benefit for patients with heart failure, reduced ejection fraction, and a widened QRS complex, according to a study published in the Jan. 18 issue of the New England Journal of Medicine.

Defibrillator 67

Defibrillator Heart Failure 67

HeartRhythm

FEBRUARY 4, 2025

The main function of the implantable cardioverter-defibrillator (ICD) is to protect against sudden cardiac death (SCD) due to ventricular tachyarrhythmia (VTA).

Heart Failure 45

Heart Failure Defibrillator Sudden Cardiac Death 45

European Journal of Heart Failure

NOVEMBER 19, 2024

Effects of sacubitril/valsartan with or without background beta-blocker therapy in patients with heart failure with reduced ejection fraction from PARADIGM-HF. The primary outcome was time to first heart failure hospitalization or cardiovascular death.

Heart Failure 76

Heart Failure Defibrillator Hospital Pulmonary 76

MIBHS

MARCH 31, 2025

Using an automated external defibrillator (AED) can help restore the heart’s rhythm until emergency medical personnel arrive. Use an automated external defibrillator (AED) if available. If someone is in cardiac arrest: Check for responsiveness and breathing. Call for emergency medical assistance immediately.

Cardiac Arrest 52

Cardiac Arrest Heart Attack Heart attacks Chest Pain 52

Frontiers in Cardiovascular Medicine

JANUARY 13, 2025

AimsThis retrospective cohort study aimed to investigate the efficacy of dual-chamber left Bundle branch pacing (LBBP) as an alternative therapy for heart failure patients with complete left bundle branch block (CLBBB) and indications for defibrillator with cardiac resynchronization therapy (CRT-D).Methods34

Defibrillator 52

Defibrillator Heart Failure Echocardiogram Cardiac Function 52

HCPLive

JANUARY 18, 2024

An analysis of the RAFT trial showed patients with heart failure treated with CRT-D experienced continued survival benefits during a median of nearly 14 years of follow-up.

Heart Failure 52

Heart Failure Defibrillator 52

European Journal of Heart Failure

JANUARY 25, 2024

Implantable devices form an integral part of the management of patients with heart failure (HF) and provide adjunctive therapies in addition to cornerstone drug treatment. Although the number of these devices is growing, only few are supported by robust evidence.

Heart Failure 68

Heart Failure Heart Rhythm Defibrillator Document 68

HeartRhythm

APRIL 30, 2024

The use of implantable cardioverter-defibrillators (ICD) for primary prevention (PP) of sudden cardiac death among select patients with heart failure (HF) is recommended by the HRS, AHA and ACC. However, whether ICDs may be underutilized within a safety-net system has not been studied.

Defibrillator 40

Defibrillator Heart Failure Sudden Cardiac Death 40

Heart BMJ

DECEMBER 15, 2023

Learning objectives Understand which patients with heart failure should be considered for a primary prevention implantable cardioverter defibrillator (ICD). Introduction Four decades ago, Mirowski et al reported on the first three humans treated with an automatic implantable defibrillator.

Defibrillator 40

Defibrillator Heart Failure Article 40

HeartRhythm

APRIL 30, 2024

Ventricular arrhythmias and heart failure are common presentations of cardiac sarcoidosis (CS). Guidelines support implantable cardioverter-defibrillator (ICD) for many CS patients with reduced ejection fraction, but arrhythmic outcomes are poorly understood.

Defibrillator 40

Defibrillator Heart Failure Arrhythmia Outcomes 40

Open Heart

SEPTEMBER 18, 2024

Introduction Wearable cardioverter-defibrillators (WCD) have emerged as a valuable tool in the management of patients at risk for life-threatening arrhythmias. These devices offer a non-invasive and temporary solution, providing continuous monitoring and the potential for prompt defibrillation when needed.

Defibrillator 52

Defibrillator Sudden Cardiac Death Arrhythmia Outpatient 52

HeartRhythm

JULY 15, 2024

Despite the abundance of evidence supporting the use of implantable cardioverter defibrillators (ICDs) for primary prevention of sudden cardiac death (SCD), racial and gender inequities in ICD implantation persist.1,2

Defibrillator 40

Defibrillator Heart Failure Sudden Cardiac Death 40

HeartRhythm

MAY 11, 2024

Trajectories of mortality after primary implantable cardioverter-defibrillator (ICD) placement for older heart failure (HF) patients during or soon after acute hospitalization have not been assessed.

Defibrillator 40

Defibrillator Heart Failure Hospital 40

HeartRhythm

OCTOBER 6, 2024

To predict worsening heart failure hospitalizations (WHFHs), the HeartInsight multiparametric algorithm calculates a Heart Failure (HF) Score based on temporal trends of physiologic parameters obtained through automatic daily remote monitoring of implantable cardioverter-defibrillators (ICDs).

Heart Failure 40

Heart Failure Defibrillator Physiology Hospital 40

American College of Cardiology

JANUARY 20, 2024

The RAFT trial sought to study the safety and efficacy of CRT-D, as compared with ICD alone in patients with mild to moderate symptoms (NYHA class II/III), LV systolic dysfunction (ejection fraction [EF] ≤30%), and wide QRS complex.

Heart Failure 53

Heart Failure Defibrillator Article 53

DAIC

MAY 17, 2024

Based on the Health Data Hub complete medico-administrative database and comprehensive datasets from Implicity's AI -based remote monitoring platform, the Implicity team trained and validated a machine learning algorithm that assesses the risk of future heart failure events, enabling physicians to intervene before a patient requires hospitalization.

Heart Failure 52

Heart Failure Pacemaker Hospital Defibrillator 52

American College of Cardiology

DECEMBER 11, 2024

The following are key points to remember from a state-of-the-art review on revisiting implantable cardioverter-defibrillator (ICD) therapy for primary prevention in patients with heart failure and reduced ejection fraction (HFrEF).

Defibrillator 75

Defibrillator Heart Failure Article 75

All About Cardiovascular System and Disorders

MARCH 17, 2024

Here is the transcript of the video: Implantable defibrillator is an important life saving device. Then, why is it mentioned that, implanting a defibrillator soon after an acute myocardial infarction, in those with left ventricular dysfunction and prone for ventricular arrhythmias and sudden cardiac death, is not useful?

Myocardial Infarction 52

Myocardial Infarction Defibrillator Sudden Cardiac Death Arrhythmia 52

Heart 2023 Conference

JULY 11, 2023

Using automated external defibrillators (AEDs) and cardiopulmonary resuscitation (CPR) as soon as possible increases a person's chance of surviving a cardiac arrest. All three outcomes had higher rates across all of the included sites in the alerted cases than in the non-alerted cases: CPR on the spot: Bystander defibrillation: 73.8%

Defibrillator 52

Defibrillator Cardiac Arrest Heart Failure RN 52

Journal of the American Heart Association

JANUARY 31, 2024

Journal of the American Heart Association, Ahead of Print. BackgroundPatients with heart failure and chronic kidney disease (CKD) may have an increased risk of death from causes competing with arrhythmic death, which could have implications for the efficacy of implantable cardioverter‐defibrillators (ICDs).

Heart Failure 40

Heart Failure Defibrillator Kidney Disease Outcomes 40

HeartRhythm

APRIL 30, 2024

Hospitalizations are common in patients with heart failure and are associated with high mortality, readmission, and economic burden. Detecting early signs of worsening heart failure allows early intervention and can reduce hospitalizations.

Heart Failure 40

Heart Failure Physiology Defibrillator Hospital 40

European Journal of Heart Failure

MARCH 19, 2025

Abstract Patients presenting with or alerting emergency networks due to acute heart failure (AHF) form a diverse group with a plethora of symptoms, risks, comorbidities, and aetiologies. Scientific guidelines provide clear recommendations for the management of arrhythmias in chronic heart failure patients.

Heart Failure 40

Heart Failure Cardiogenic Shock Arrhythmia Heart Rhythm 40

European Journal of Heart Failure

JANUARY 9, 2025

Heart failure (HF) duration and guideline-recommended therapy implementation. Additionally, 18% received cardiac resynchronization therapy/implantable cardioverter-defibrillator >12months after diagnosis. The extent to which this occurs in new-onset HFrEF is unclear.

Heart Failure 40

Heart Failure Defibrillator Research Article 40

HeartRhythm

APRIL 30, 2024

Implantable cardiac defibrillators (ICDs) are a fundamental therapy used in the prevention of sudden cardiac death (SCD). With our aging population and with advances in medical therapy for heart failure, navigating the decision-making process for ICDs in these patients(pts) becomes essential.

Defibrillator 40

Defibrillator Sudden Cardiac Death Heart Failure Outcomes 40

Medical Xpress - Cardiology

JULY 29, 2024

Patients with congestive heart failure (CHF) having a compromised blood supply, are at greater risk of sudden cardiac death (SCD). With an estimated incidence as high as 22% among these patients, current clinical guidelines recommend using implantable cardioverter defibrillators (ICDs) to help mitigate the risk of SCD.

Sudden Cardiac Death 40

Sudden Cardiac Death Heart Failure Defibrillator 40

Open Heart

SEPTEMBER 1, 2022

Identifying patients with high-risk heart failure (HF) who would benefit from an implantable cardioverter-defibrillator (ICD) remains controversial. A potential marker for arrhythmic sudden death is fragmented QRS (fQRS).

Heart Failure 52

Heart Failure Arrhythmia Defibrillator 52

HeartRhythm

OCTOBER 17, 2024

The HeartLogic algorithm (Boston Scientific, St Paul, MN) integrates data from implantable cardioverter-defibrillator (ICD) sensors to predict heart failure (HF) decompensation: first (S1) and third (S3) heart sounds, intrathoracic impedance, respiration rate, ratio of respiration rate to tidal volume (RSBI), and night heart rate.

Heart Failure 40

Heart Failure Defibrillator 40

HeartRhythm

APRIL 30, 2024

We have previously shown an association between metabolic syndrome (MS) and heart failure (HF) outcomes in patients with implanted defibrillators (ICD) and cardiac resynchronization therapy (CRT-D). However, the role of MS and diabetes in predicting HF outcomes was not assessed in non-obese patients.

Heart Failure 40

Heart Failure Obesity Diabetes Outcomes 40

Dr. Smith's ECG Blog

APRIL 2, 2024

He was defibrillated, but they also noticed that he was being internally defibrillated and then found that he had an implantable ICD. He was unidentified and there were no records available After 7 shocks, he was successfully defibrillated and brought to the ED. There was no bystander CPR.

Tachycardia 133

Tachycardia Pacemaker Cardiac Arrest Cardiomyopathy 133

HeartRhythm

NOVEMBER 21, 2024

There are limited data on clinical and arrhythmic outcomes following a first ventricular tachyarrhythmia (VTA) in heart failure (HF) patients who receive a primary prevention implantable cardioverter-defibrillator (ICD).

Defibrillator 40

Defibrillator Heart Failure Outcomes 40

HeartRhythm

APRIL 30, 2024

However, the prevalence of frequent PVCs among patients with heart failure with reduced ejection fraction (HFrEF) and the impact of cardiac resynchronization therapy (CRT) on PVC burden is unknown. Frequent premature ventricular complexes are associated with the development of left ventricular dysfunction.

Heart Failure 40

Heart Failure Defibrillator 40

HeartRhythm

APRIL 30, 2024

In part due to advances in guideline-directed medical therapy (GDMT) and availability of implantable cardioverter-defibrillators (ICDs), cardiac arrest (CA) rates among patients with heart Failure (HF) decreased in the early 2000s. Relatively little is known about trends in CA associated with HF over the past decade.

Cardiac Arrest 40

Cardiac Arrest Heart Failure Defibrillator 40

Dr. Sanjay Gupta

MAY 23, 2022

Today’s vlog is on the subject of heart failure and in particular on a special type of pacemaker which can make a significant improvement to the quality of life and length of life in patients with heart failure. What is heart failure? You can download this script as a Hindi translation here.

Heart Failure 40

Heart Failure Pacemaker Quality of Life ACE Inhibitor 40

HeartRhythm

APRIL 30, 2024

For the past four decades, implantable cardioverter defibrillator (ICD) therapy has become the standard of care for preventing sudden cardiac death in high-risk individuals. Patients with ICDs who experience atrial fibrillation (AF) have a higher risk of stroke, heart failure, and mortality.

Atrial Fibrillation 40

Atrial Fibrillation Defibrillator Sudden Cardiac Death Tachycardia 40

HeartRhythm

SEPTEMBER 5, 2024

The heterogeneity among SCD victims, ranging from individuals with severe heart failure to seemingly healthy individuals, poses a significant challenge for effective risk assessment.

Sudden Cardiac Death 68

Sudden Cardiac Death Defibrillator Heart Failure 68

Open Heart

NOVEMBER 28, 2022

Background Remote monitoring (RM) of cardiac implantable electronic devices (CIEDs) is now the standard of care, but whether the demonstrated benefits of RM translate into improvements in heart failure (HF) management is controversial. This systematic review addresses the role of RM in patients with HF with a CIED.

Heart Failure 52

Heart Failure Defibrillator Article Hospital 52

HeartRhythm

OCTOBER 8, 2024

Amongst patients with left ventricular systolic dysfunction and prolonged QRS duration, cardiac resynchronization therapy (CRT) can improve cardiac electromechanical synchrony, and prevent adverse clinical outcomes.

Heart Failure 45

Heart Failure Defibrillator Outcomes 45